 | • レポートコード：D0GIR-02361 • 出版社/出版日：GlobalInfoResearch / 2020年9月23日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥508,080 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥762,120 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,016,160 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、抗真菌薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。抗真菌薬の種類別市場規模（経口投与、外用）、用途別市場規模（病院薬局、小売薬局、ドラッグストア、オンライン販売）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Novartis (Switzerland)、Merck (U.S)、Pfizer (U.S)、Sanofi (France)、Bayer (Germany)、Astellas (Japan) ・地域別グローバル市場分析 2015年-2020年 ・抗真菌薬の北米市場（アメリカ、カナダ、メキシコ） ・抗真菌薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・抗真菌薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・抗真菌薬の南米市場（ブラジル、アルゼンチン） ・抗真菌薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：経口投与、外用 ・用途別分析：病院薬局、小売薬局、ドラッグストア、オンライン販売 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Antifungal market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Antifungal market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Antifungal market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Antifungal market has been segmented into:
Oral Administration
External Use
By Application, Antifungal has been segmented into:
Hospital Pharmacies
Retail Pharmacies
Drug Stores
Online Sales
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Antifungal market presented in the report. This section sheds light on the sales growth of different regional and country-level Antifungal markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Antifungal market.
The report offers in-depth assessment of the growth and other aspects of the Antifungal market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Antifungal Market Share Analysis
Antifungal competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Antifungal sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Antifungal sales, revenue and market share for each player covered in this report.
The major players covered in Antifungal are:
Novartis (Switzerland)
Merck (U.S)
Pfizer (U.S)
Sanofi (France)
Bayer (Germany)
Astellas (Japan)
Table of Contents
1 Antifungal Market Overview
1.1 Product Overview and Scope of Antifungal
1.2 Classification of Antifungal by Type
1.2.1 Global Antifungal Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Antifungal Revenue Market Share by Type in 2019
1.2.3 Oral Administration
1.2.4 External Use
1.3 Global Antifungal Market by Application
1.3.1 Overview: Global Antifungal Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Drug Stores
1.3.5 Online Sales
1.4 Global Antifungal Market by Regions
1.4.1 Global Antifungal Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Antifungal (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Antifungal Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Antifungal Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Antifungal Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Antifungal Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Antifungal Status and Prospect (2015-2025)
2 Company Profiles
2.1 Novartis (Switzerland)
2.1.1 Novartis (Switzerland) Details
2.1.2 Novartis (Switzerland) Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Novartis (Switzerland) SWOT Analysis
2.1.4 Novartis (Switzerland) Product and Services
2.1.5 Novartis (Switzerland) Antifungal Revenue, Gross Margin and Market Share (2018-2019)
2.2 Merck (U.S)
2.2.1 Merck (U.S) Details
2.2.2 Merck (U.S) Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Merck (U.S) SWOT Analysis
2.2.4 Merck (U.S) Product and Services
2.2.5 Merck (U.S) Antifungal Revenue, Gross Margin and Market Share (2018-2019)
2.3 Pfizer (U.S)
2.3.1 Pfizer (U.S) Details
2.3.2 Pfizer (U.S) Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Pfizer (U.S) SWOT Analysis
2.3.4 Pfizer (U.S) Product and Services
2.3.5 Pfizer (U.S) Antifungal Revenue, Gross Margin and Market Share (2018-2019)
2.4 Sanofi (France)
2.4.1 Sanofi (France) Details
2.4.2 Sanofi (France) Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Sanofi (France) SWOT Analysis
2.4.4 Sanofi (France) Product and Services
2.4.5 Sanofi (France) Antifungal Revenue, Gross Margin and Market Share (2018-2019)
2.5 Bayer (Germany)
2.5.1 Bayer (Germany) Details
2.5.2 Bayer (Germany) Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Bayer (Germany) SWOT Analysis
2.5.4 Bayer (Germany) Product and Services
2.5.5 Bayer (Germany) Antifungal Revenue, Gross Margin and Market Share (2018-2019)
2.6 Astellas (Japan)
2.6.1 Astellas (Japan) Details
2.6.2 Astellas (Japan) Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Astellas (Japan) SWOT Analysis
2.6.4 Astellas (Japan) Product and Services
2.6.5 Astellas (Japan) Antifungal Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Antifungal Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Antifungal Players Market Share
3.2.2 Top 10 Antifungal Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Antifungal Revenue and Market Share by Regions
4.2 North America Antifungal Revenue and Growth Rate (2015-2020)
4.3 Europe Antifungal Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Antifungal Revenue and Growth Rate (2015-2020)
4.5 South America Antifungal Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Antifungal Revenue and Growth Rate (2015-2020)
5 North America Antifungal Revenue by Countries
5.1 North America Antifungal Revenue by Countries (2015-2020)
5.2 USA Antifungal Revenue and Growth Rate (2015-2020)
5.3 Canada Antifungal Revenue and Growth Rate (2015-2020)
5.4 Mexico Antifungal Revenue and Growth Rate (2015-2020)
6 Europe Antifungal Revenue by Countries
6.1 Europe Antifungal Revenue by Countries (2015-2020)
6.2 Germany Antifungal Revenue and Growth Rate (2015-2020)
6.3 UK Antifungal Revenue and Growth Rate (2015-2020)
6.4 France Antifungal Revenue and Growth Rate (2015-2020)
6.5 Russia Antifungal Revenue and Growth Rate (2015-2020)
6.6 Italy Antifungal Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Antifungal Revenue by Countries
7.1 Asia-Pacific Antifungal Revenue by Countries (2015-2020)
7.2 China Antifungal Revenue and Growth Rate (2015-2020)
7.3 Japan Antifungal Revenue and Growth Rate (2015-2020)
7.4 Korea Antifungal Revenue and Growth Rate (2015-2020)
7.5 India Antifungal Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Antifungal Revenue and Growth Rate (2015-2020)
8 South America Antifungal Revenue by Countries
8.1 South America Antifungal Revenue by Countries (2015-2020)
8.2 Brazil Antifungal Revenue and Growth Rate (2015-2020)
8.3 Argentina Antifungal Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Antifungal by Countries
9.1 Middle East & Africa Antifungal Revenue by Countries (2015-2020)
9.2 Saudi Arabia Antifungal Revenue and Growth Rate (2015-2020)
9.3 UAE Antifungal Revenue and Growth Rate (2015-2020)
9.4 Egypt Antifungal Revenue and Growth Rate (2015-2020)
9.5 South Africa Antifungal Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Antifungal Revenue and Market Share by Type (2015-2020)
10.2 Global Antifungal Market Forecast by Type (2019-2024)
10.3 Oral Administration Revenue Growth Rate (2015-2025)
10.4 External Use Revenue Growth Rate (2015-2025)
11 Global Antifungal Market Segment by Application
11.1 Global Antifungal Revenue Market Share by Application (2015-2020)
11.2 Antifungal Market Forecast by Application (2019-2024)
11.3 Hospital Pharmacies Revenue Growth (2015-2020)
11.4 Retail Pharmacies Revenue Growth (2015-2020)
11.5 Drug Stores Revenue Growth (2015-2020)
11.6 Online Sales Revenue Growth (2015-2020)
12 Global Antifungal Market Size Forecast (2021-2025)
12.1 Global Antifungal Market Size Forecast (2021-2025)
12.2 Global Antifungal Market Forecast by Regions (2021-2025)
12.3 North America Antifungal Revenue Market Forecast (2021-2025)
12.4 Europe Antifungal Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Antifungal Revenue Market Forecast (2021-2025)
12.6 South America Antifungal Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Antifungal Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Antifungal Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Antifungal by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Antifungal Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Antifungal Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Novartis (Switzerland) Corporate Information, Location and Competitors
Table 6. Novartis (Switzerland) Antifungal Major Business
Table 7. Novartis (Switzerland) Antifungal Total Revenue (USD Million) (2017-2018)
Table 8. Novartis (Switzerland) SWOT Analysis
Table 9. Novartis (Switzerland) Antifungal Product and Solutions
Table 10. Novartis (Switzerland) Antifungal Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Merck (U.S) Corporate Information, Location and Competitors
Table 12. Merck (U.S) Antifungal Major Business
Table 13. Merck (U.S) Antifungal Total Revenue (USD Million) (2018-2019)
Table 14. Merck (U.S) SWOT Analysis
Table 15. Merck (U.S) Antifungal Product and Solutions
Table 16. Merck (U.S) Antifungal Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Pfizer (U.S) Corporate Information, Location and Competitors
Table 18. Pfizer (U.S) Antifungal Major Business
Table 19. Pfizer (U.S) Antifungal Total Revenue (USD Million) (2017-2018)
Table 20. Pfizer (U.S) SWOT Analysis
Table 21. Pfizer (U.S) Antifungal Product and Solutions
Table 22. Pfizer (U.S) Antifungal Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Sanofi (France) Corporate Information, Location and Competitors
Table 24. Sanofi (France) Antifungal Major Business
Table 25. Sanofi (France) Antifungal Total Revenue (USD Million) (2017-2018)
Table 26. Sanofi (France) SWOT Analysis
Table 27. Sanofi (France) Antifungal Product and Solutions
Table 28. Sanofi (France) Antifungal Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Bayer (Germany) Corporate Information, Location and Competitors
Table 30. Bayer (Germany) Antifungal Major Business
Table 31. Bayer (Germany) Antifungal Total Revenue (USD Million) (2017-2018)
Table 32. Bayer (Germany) SWOT Analysis
Table 33. Bayer (Germany) Antifungal Product and Solutions
Table 34. Bayer (Germany) Antifungal Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Astellas (Japan) Corporate Information, Location and Competitors
Table 36. Astellas (Japan) Antifungal Major Business
Table 37. Astellas (Japan) Antifungal Total Revenue (USD Million) (2017-2018)
Table 38. Astellas (Japan) SWOT Analysis
Table 39. Astellas (Japan) Antifungal Product and Solutions
Table 40. Astellas (Japan) Antifungal Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Global Antifungal Revenue (Million USD) by Players (2015-2020)
Table 42. Global Antifungal Revenue Share by Players (2015-2020)
Table 43. Global Antifungal Revenue (Million USD) by Regions (2015-2020)
Table 44. Global Antifungal Revenue Market Share by Regions (2015-2020)
Table 45. North America Antifungal Revenue by Countries (2015-2020)
Table 46. North America Antifungal Revenue Market Share by Countries (2015-2020)
Table 47. Europe Antifungal Revenue (Million USD) by Countries (2015-2020)
Table 48. Asia-Pacific Antifungal Revenue (Million USD) by Countries (2015-2020)
Table 49. South America Antifungal Revenue by Countries (2015-2020)
Table 50. South America Antifungal Revenue Market Share by Countries (2015-2020)
Table 51. Middle East and Africa Antifungal Revenue (Million USD) by Countries (2015-2020)
Table 52. Middle East and Africa Antifungal Revenue Market Share by Countries (2015-2020)
Table 53. Global Antifungal Revenue (Million USD) by Type (2015-2020)
Table 54. Global Antifungal Revenue Share by Type (2015-2020)
Table 55. Global Antifungal Revenue Forecast by Type (2021-2025)
Table 56. Global Antifungal Revenue by Application (2015-2020)
Table 57. Global Antifungal Revenue Share by Application (2015-2020)
Table 58. Global Antifungal Revenue Forecast by Application (2021-2025)
Table 59. Global Antifungal Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Antifungal Picture
Figure 2. Global Antifungal Revenue Market Share by Type in 2019
Figure 3. Oral Administration Picture
Figure 4. External Use Picture
Figure 5. Antifungal Revenue Market Share by Application in 2019
Figure 6. Hospital Pharmacies Picture
Figure 7. Retail Pharmacies Picture
Figure 8. Drug Stores Picture
Figure 9. Online Sales Picture
Figure 10. Global Antifungal Revenue (USD Million) and Growth Rate (2015-2025)
Figure 11. North America Antifungal Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Europe Antifungal Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Asia-Pacific Antifungal Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. South America Antifungal Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Middle East and Africa Antifungal Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Antifungal Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Antifungal Revenue Share by Players in 2019
Figure 18. Global Top 5 Players Antifungal Revenue Market Share in 2019
Figure 19. Global Top 10 Players Antifungal Revenue Market Share in 2019
Figure 20. Key Players Market Share Trend
Figure 21. Global Antifungal Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 22. Global Antifungal Revenue Market Share by Regions (2015-2020)
Figure 23. Global Antifungal Revenue Market Share by Regions in 2018
Figure 24. North America Antifungal Revenue and Growth Rate (2015-2020)
Figure 25. Europe Antifungal Revenue and Growth Rate (2015-2020)
Figure 26. Asia-Pacific Antifungal Revenue and Growth Rate (2015-2020)
Figure 27. South America Antifungal Revenue and Growth Rate (2015-2020)
Figure 28. Middle East and Africa Antifungal Revenue and Growth Rate (2015-2020)
Figure 29. North America Antifungal Revenue Market Share by Countries (2015-2020)
Figure 30. North America Antifungal Revenue Market Share by Countries in 2019
Figure 31. USA Antifungal Revenue and Growth Rate (2015-2020)
Figure 32. Canada Antifungal Revenue and Growth Rate (2015-2020)
Figure 33. Mexico Antifungal Revenue and Growth Rate (2015-2020)
Figure 34. Europe Antifungal Revenue Market Share by Countries (2015-2020)
Figure 35. Europe Antifungal Revenue Market Share by Countries in 2019
Figure 36. Germany Antifungal Revenue and Growth Rate (2015-2020)
Figure 37. UK Antifungal Revenue and Growth Rate (2015-2020)
Figure 38. France Antifungal Revenue and Growth Rate (2015-2020)
Figure 39. Russia Antifungal Revenue and Growth Rate (2015-2020)
Figure 40. Italy Antifungal Revenue and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Antifungal Revenue Market Share by Countries (2015-2020)
Figure 42. Asia-Pacific Antifungal Revenue Market Share by Countries in 2019
Figure 43. China Antifungal Revenue and Growth Rate (2015-2020)
Figure 44. Japan Antifungal Revenue and Growth Rate (2015-2020)
Figure 45. Korea Antifungal Revenue and Growth Rate (2015-2020)
Figure 46. India Antifungal Revenue and Growth Rate (2015-2020)
Figure 47. Southeast Asia Antifungal Revenue and Growth Rate (2015-2020)
Figure 48. South America Antifungal Revenue Market Share by Countries (2015-2020)
Figure 49. South America Antifungal Revenue Market Share by Countries in 2019
Figure 50. Brazil Antifungal Revenue and Growth Rate (2015-2020)
Figure 51. Argentina Antifungal Revenue and Growth Rate (2015-2020)
Figure 52. Middle East and Africa Antifungal Revenue Market Share by Countries (2015-2020)
Figure 53. Middle East and Africa Antifungal Revenue Market Share by Countries in 2019
Figure 54. Saudi Arabia Antifungal Revenue and Growth Rate (2015-2020)
Figure 55. UAE Antifungal Revenue and Growth Rate (2015-2020)
Figure 56. Egypt Antifungal Revenue and Growth Rate (2015-2020)
Figure 57. South Africa Antifungal Revenue and Growth Rate (2015-2020)
Figure 58. Global Antifungal Revenue Share by Type (2015-2020)
Figure 59. Global Antifungal Revenue Share by Type in 2019
Figure 60. Global Antifungal Market Share Forecast by Type (2021-2025)
Figure 61. Global Oral Administration Revenue Growth Rate (2015-2020)
Figure 62. Global External Use Revenue Growth Rate (2015-2020)
Figure 63. Global Antifungal Revenue Share by Application (2015-2020)
Figure 64. Global Antifungal Revenue Share by Application in 2019
Figure 65. Global Antifungal Market Share Forecast by Application (2021-2025)
Figure 66. Global Hospital Pharmacies Revenue Growth Rate (2015-2020)
Figure 67. Global Retail Pharmacies Revenue Growth Rate (2015-2020)
Figure 68. Global Drug Stores Revenue Growth Rate (2015-2020)
Figure 69. Global Online Sales Revenue Growth Rate (2015-2020)
Figure 70. Global Antifungal Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 71. Global Antifungal Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 72. Global Antifungal Revenue Market Share Forecast by Regions (2021-2025)
Figure 73. North America Antifungal Revenue Market Forecast (2021-2025)
Figure 74. Europe Antifungal Revenue Market Forecast (2021-2025)
Figure 75. Asia-Pacific Antifungal Revenue Market Forecast (2021-2025)
Figure 76. South America Antifungal Revenue Market Forecast (2021-2025)
Figure 77. Middle East and Africa Antifungal Revenue Market Forecast (2021-2025)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
ポリエン抗真菌薬APIの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Polyene Antifungal Drugs API market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimi…- 抗真菌剤の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Antifungal Agents market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.4% in the forecast period of 2020 to 2025 and will expected to reach USD 12560 million by 2025, from USD 11400 million in 2019. The Antifungal Agents ma…
- 眼炎症治療薬の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Ocular Inflammation Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.3% in the forecast period of 2020 to 2025 and will expected to reach USD 25570 million by 2025, from USD 20810 million in 2019. The Ocular I…
- CARD9欠乏症治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The CARD9 Deficiency Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiza…
- 感染症治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Infectious Disease Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.1% in the forecast period of 2020 to 2025 and will expected to reach USD 59530 million by 2025, from USD 48760 million in 2019. The Infectiou…